MLTX

MoonLake Immunotherapeutics Class A

MLTX·61559X104·US·Common Stock·Healthcare - Biotechnology-Activist

MLTX (MoonLake Immunotherapeutics Class A) is held by 87 institutional investors as of Q2 2026. Largest holders: D. E. Shaw & Co., Inc. ($65.5M), CITADEL ADVISORS LLC ($38.4M), TWO SIGMA INVESTMENTS, LP ($33.4M). Net institutional sentiment: Bullish.

87
Holders
(8 Elite)
$440.4M
Total Value
67% (88)
Consensus
59 buying - 29 selling
13F: Insider & Congress: Updated regularly
MLTX

Smart Money Verdict

View all
Loading verdict
Held by 87 funds
8 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jul 29, 2026 · Activists Aug 14, 2026 · Congress none

ActivistCACormorant Asset Management, LP4.3%Aug 14, 2026
ActivistTRT. Rowe Price Investment Management, Inc.5.3%Aug 14, 2026
ActivistDTDeep Track Capital, LP9.7%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.4M(+40.8%)$65.5M0.0%+3.97%
39
Increased
2M(+49.0%)$38.4M0.0%-10.73%
40
Increased
1.7M(+52.8%)$33.4M0.0%+8.40%
40
Increased
1.4M(+27.4%)$27.6M0.0%+5.61%
36
Decreased
1.2M(-15.3%)$22.6M0.0%+1.38%
0
Increased
1.1M(+7.1%)$21.3M0.0%-26.03%
31
Decreased
912,715(-14.3%)$17.8M0.0%-6.35%
0
Increased
853,386(+88.1%)$16.6M0.0%-2.95%
44
Decreased
769,766(-5.9%)$15M0.1%-35.68%
0
Increased
751,897(+3.7%)$14.6M0.0%-12.14%
29
Increased
750,777(+970.4%)$14.6M0.0%-19.08%
45
Increased
643,268(+132.4%)$12.5M0.0%-12.09%
45
Increased
636,187(+10.4%)$12.4M0.0%+19.23%
31
Decreased
563,602(-8.3%)$11M0.0%+18.98%
0
Increased
550,351(+394.3%)$10.7M0.0%-18.26%
45
Increased
496,242(+1056.3%)$9.7M0.0%-19.13%
45
Decreased
377,946(-23.7%)$7.4M0.0%-2.52%
0
Increased
358,884(+677.1%)$7M0.0%-17.05%
44
Increased
341,537(+42.4%)$6.6M0.0%-16.75%
37
Increased
328,522(+8369.2%)$6.4M0.0%-19.95%
44

Showing 1-20 of 91

1 / 5
MLTXMLTXMoonLake Immunotherapeutics Class A

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used